Discover trends, market shifts, and competitive outlooks for the cancer immunotherapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Cancer Immunotherapy Market, and What Factors Will Drive It?

The market size for cancer immunotherapy has seen rapid expansion recently. Its growth trajectory is projected to take it from $110.91 billion in 2024 to $125.68 billion in 2025, yielding a compound annual growth rate (CAGR) of 13.3%. Factors such as a growing prevalence of cancer, higher preference for immunotherapy over traditional therapy, an increase in research and development activities for disease targeting, improved efficiency and precision of modern therapies, as well as growing acknowledgment of the limitations of conventional cancer treatments, have contributed to the growth observed during the historic period.

In the coming years, the market size for cancer immunotherapy is projected to experience significant growth, expanding to $194.64 billion in 2029 with a compound annual growth rate (CAGR) of 11.6%. The anticipated growth throughout this period can be credited to factors such as the rising approval numbers of new immunotherapies for cancer treatment, an increasing demand for individualized medicine, an escalation in the detection of cancer cases, considerable investment in clinical trials to develop breakthrough treatments, and heightened awareness of cancer immunotherapy. The forecast period may also see notable trends such as the rise of adoptive cell therapies, such as car-t cells, further investigation into oncolytic viruses in cancer immunotherapy, the formulation of personalized cancer vaccines, the employment of artificial intelligence in immunotherapy research, and an increased focus on real-world evidence and patient outcomes in making treatment decisions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

What are the Fundamental Drivers and Innovations Shaping the Cancer Immunotherapy Market?

Escalating occurrences of cancer are projected to drive the cancer immunotherapy market forward. The rise in cases of cancer worldwide can be attributed to factors such as tobacco use, alcohol consumption, obesity, sedentary lifestyles, and environmental elements. The surge in cancer diagnoses is likely to stimulate demand for cancer immunotherapy, as patients are progressively investing in medical treatments that offer higher recovery rates and minimal pain. For instance, as stated by the Belgium-based European Commission’s Joint Research Centre, the European Union Science Hub, in October 2023, new cancer cases had risen by 2.3% over the previous two years, tallying up to 2.74 million in 2022. Similarly, cancer-related deaths escalated by 2.4% over the previous two years. Consequently, the heightened incidence of cancer is predicted to spur the demand for cancer immunotherapy during the forecast period.

How Is the Cancer Immunotherapy Market Segmented?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp

Which Regions Are Driving the Next Phase of the Cancer Immunotherapy Market Growth?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Cancer Immunotherapy Market?

The rise of sophisticated technologies in cancer immunotherapy is an emerging trend in the cancer immunotherapy market. Numerous innovative technologies and therapies have been developed to aid the immune system in recognizing and combatting tumors, utilizing various forms of therapy such as immuno-oncology, cryoablation, bone marrow transplantation, and radiation. These technologies hold promise to significantly influence cancer management and recovery. For example, AstraZeneca plc, a pharmaceutical and biotech firm based in the UK, announced in October 2022 that their drug, Capivasertib in combination with Faslodex, had gained approval. This drug, a cancer immunotherapeutic agent, was engineered for the treatment of breast cancer, proving effective post-recurrence or progression subsequent to endocrine therapy in locally advanced or metastatic breast cancer that is low or negative for human epidermal growth factor receptor 2 (HER2).

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

How Is the Cancer Immunotherapy Market Defined and What Are Its Core Parameters?

Cancer immunotherapy refers to a type of cancer therapy that strengthens your body’s defenses against the disease. Your body’s immune system aids in the defense against infections and other disorders. White blood cells, organs, and lymphatic system tissues make up this substance. Cancer immunotherapy comes in various forms, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, tumor-infecting viruses, and others.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6768

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model